← Open Payments lookup

MICHAEL BYRD: Open Payments

NPI 1255094678 · MILLEDGEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,316 in 41 payments from 9 companies in 2025. Trend: 2023 $517 · 2024 $648 · 2025 $1,316

Food & beverage: $1,310Education: $5
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$416
E.R. Squibb & Sons, L.L.C.5$236
Janssen Pharmaceuticals, Inc7$192
Teva Pharmaceuticals USA, Inc.7$184
Supernus Pharmaceuticals, Inc.4$95
Otsuka America Pharmaceutical, Inc.3$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Alkermes, Inc.1$31
Lundbeck LLC1$27

Products named: INGREZZA, COBENFY, INVEGA SUSTENNA, UZEDY, Qelbree, CAPLYTA, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across GA — which companies pay providers there.